<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02900833</url>
  </required_header>
  <id_info>
    <org_study_id>JDS_2015_46</org_study_id>
    <nct_id>NCT02900833</nct_id>
  </id_info>
  <brief_title>Impact of Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy</brief_title>
  <acronym>NEUTROSTROKE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <brief_summary>
    <textblock>
      Clinical and experimental data suggest that neutrophil activation and extravasation are
      deleterious in acute ischemic stroke (AIS) involving an increased risk of unfavorable outcome
      and hemorrhagic transformation (HT). However, clinical trials targeting neutrophil
      recruitment in AIS patients were negative. Recently, an experimental study has shown that
      neutrophil activation and transmigration begin immediately after the occlusion. Inhibition of
      neutrophil recruitment several hours after the start of ischemia appears therefore too late
      to have a clinical relevance.

      The objective is to study the time dependent impact of neutrophils in AIS and the predominant
      mediators in each time point to identify the appropriate therapeutic target and time window.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 24, 2016</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>neutrophil counts</measure>
    <time_frame>before recanalization</time_frame>
    <description>Plasma neutrophil activation bio-markers</description>
  </primary_outcome>
  <primary_outcome>
    <measure>neutrophil counts</measure>
    <time_frame>immediately after recanalization</time_frame>
    <description>Plasma neutrophil activation bio-markers</description>
  </primary_outcome>
  <primary_outcome>
    <measure>neutrophil counts</measure>
    <time_frame>24 hours after recanalization</time_frame>
    <description>Plasma neutrophil activation bio-markers</description>
  </primary_outcome>
  <primary_outcome>
    <measure>neutrophil protease counts</measure>
    <time_frame>before recanalization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>recanalization score</measure>
    <time_frame>immediately after endovascular procedure</time_frame>
    <description>Thrombolysis in Cerebral Infarction classification (TICI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>acute ischemic stroke etiology</measure>
    <time_frame>within 24 hours after endovascular procedure</time_frame>
    <description>as defined by the Trial of Danaparoid (ORG10172) in Acute Stroke Treatment (TOAST classification)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>severity of neurologic symptoms</measure>
    <time_frame>baseline</time_frame>
    <description>National Institutes of Health Stroke Scale (NIHSS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>disruption of the blood-brain-barrier</measure>
    <time_frame>within 24 hours after endovascular procedure</time_frame>
    <description>diagnosis on cerebral Computerized Tomography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brain haemorrhage</measure>
    <time_frame>24 hours after endovascular procedure</time_frame>
    <description>National Institutes of Health Stroke Scale (NIHSS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recovery of motor function after stroke</measure>
    <time_frame>3 months</time_frame>
    <description>modified Rankin scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>adhesion molecules counts</measure>
    <time_frame>before recanalization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>adhesion molecules counts</measure>
    <time_frame>immediately after recanalization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>adhesion molecules counts</measure>
    <time_frame>24 hours after recanalization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>free plasma DNA counts</measure>
    <time_frame>before recanalization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>free plasma DNA counts</measure>
    <time_frame>immediately after recanalization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>free plasma DNA counts</measure>
    <time_frame>24 hours after recanalization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>neutrophil protease counts</measure>
    <time_frame>immediately after recanalization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>neutrophil protease counts</measure>
    <time_frame>24 hours after recanalization</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Acute Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute ischemic stroke secondary to a large vessel occlusion, undergoing
        endovascular therapy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;= 18 years old

          -  acute ischemic stroke secondary to a large vessel occlusion.

          -  Patients hospitalized for endovascular therapy.

        Exclusion Criteria:

          -  Pregnant or breast feeding patient

          -  patient under legal protection

          -  Patient opposition to participate in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Philippe DESILLES, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation OPH A de Rothschild</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mikael MAZIGHI, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Fondation OPH A de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence SALOMON, MD, PhD</last_name>
    <phone>0033148036431</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence SALOMON, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2016</study_first_submitted>
  <study_first_submitted_qc>September 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2016</study_first_posted>
  <last_update_submitted>March 12, 2018</last_update_submitted>
  <last_update_submitted_qc>March 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

